GlassScriptPhysician profile
Kenneth M Kirschner
NPI 1205847332
$3,195.57
in general payments reported to CMS, 2019-2025
13 companies · $494 in 2025
The $494 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $274 · 2021: $314 · 2022: $652 · 2023: $310 · 2024: $861 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,664.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,121.54 | 2019-2024 | Total30, Precision 1, Dailies |
| Bausch & Lomb Americas INC. | $604.77 | 2022-2025 | Infuse, Biotrue One Day, Miebo |
| Coopervision INC. | $577.24 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Harrow Eye, LLC | $186.28 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $142.44 | 2024-2025 | |
| Johnson & Johnson Vision Care, INC. | $133.73 | 2024-2025 | Acuvue |
| Abbvie INC. | $118.03 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $82.83 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $65.79 | 2024-2025 | Xdemvy |
| Shire North American Group INC | $53.90 | 2019 | |
| Oyster Point Pharma, INC. | $50.24 | 2022 | |
| Sight Sciences, INC. | $39.16 | 2019-2020 | |
| Allergan, INC. | $19.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Kirschner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.